Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, +47

Cell

Structure-guided High-resolution SerologyVirus StructureImmunodominant SitesImmunologyReceptor (Biochemistry) +3

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, +256

Nature

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, +53

Nature

VaccinationNeutralizing AntibodiesVaccine TargetHumoral ResponseImmunology +4

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, +18

Nature

VaccinationVaccine DevelopmentImmunologyVirologySars-cov-2 B.1.1.7 +2

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Emma C. Thomson, Laura E. Rosen, James G. Shepherd, +63

Cell

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

Tyler N. Starr, Nadine Czudnochowski, Zhuoming Liu, +54

Nature

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

Matthew McCallum, Jessica Bassi, Anna De Marco, +29

Science

VaccinationNovel VariantViral EvolutionVaccine DevelopmentVaccine Target +13

Broad betacoronavirus neutralization by a stem helix–specific human antibody

Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, +49

Science

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

Young‐Jun Park, Dora Pinto, Alexandra C. Walls, +49

Science

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, +53

Nature

VaccinationNeutralizing AntibodiesVaccine TargetHumoral ResponseImmunology +4